Quick Answer
TENAX THERAPEUTICS, INC. reported Gross Profit of $0.00 for the year ending 2016.
- This data is from TENAX THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2017.
- XBRL data for this metric is available from 2011 to 2016 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $5.1 thousand | Q4 2010: $27.1 thousand | Q1 2011: $26.6 thousand | Q3 2011: $24.9 thousand | Q4 2011: $16.9 thousand | Q1 2012: $2.2 thousand | Q3 2012: $5.5 thousand | Q4 2012: $5.4 thousand | Q1 2013: $1.3 thousand | Q3 2013: $7.9 thousand | Q4 2013: $21.3 thousand | Q1 2014: $180.00 | Q3 2014: $0.00 | Q4 2014: $0.00 | Q1 2015: $0.00.
- Over the full 6 years of available data (2011 to 2016), TENAX THERAPEUTICS, INC.'s Gross Profit has declined by 100.0%.
- Historical annual values: Fiscal year 2016: $0.00 | Fiscal year 2015: $0.00 | Fiscal year 2014: -$104.1 thousand | Fiscal year 2013: $49.6 thousand | Fiscal year 2012: $49.3 thousand | Fiscal year 2011: $103.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: